Logo image of ACCS

ACCESS NEWSWIRE INC (ACCS) Stock Fundamental Analysis

NYSEARCA:ACCS - NYSE Arca - US46520M2044 - Common Stock - Currency: USD

10.1151  +0.02 (+0.15%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ACCS. ACCS was compared to 283 industry peers in the Software industry. ACCS may be in some trouble as it scores bad on both profitability and health. ACCS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ACCS had positive earnings in the past year.
ACCS had a positive operating cash flow in the past year.
Of the past 5 years ACCS 4 years were profitable.
ACCS had a positive operating cash flow in each of the past 5 years.
ACCS Yearly Net Income VS EBIT VS OCF VS FCFACCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

ACCS has a Return On Assets (-11.14%) which is comparable to the rest of the industry.
With a Return On Equity value of -17.05%, ACCS perfoms like the industry average, outperforming 45.94% of the companies in the same industry.
Industry RankSector Rank
ROA -11.14%
ROE -17.05%
ROIC N/A
ROA(3y)-5.74%
ROA(5y)-0.56%
ROE(3y)-11.6%
ROE(5y)-3.38%
ROIC(3y)N/A
ROIC(5y)N/A
ACCS Yearly ROA, ROE, ROICACCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

With a decent Gross Margin value of 77.19%, ACCS is doing good in the industry, outperforming 73.14% of the companies in the same industry.
In the last couple of years the Gross Margin of ACCS has grown nicely.
ACCS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.85%
GM growth 5Y1.91%
ACCS Yearly Profit, Operating, Gross MarginsACCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

3

2. Health

2.1 Basic Checks

ACCS does not have a ROIC to compare to the WACC, probably because it is not profitable.
ACCS has more shares outstanding than it did 1 year ago.
ACCS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ACCS has a worse debt to assets ratio.
ACCS Yearly Shares OutstandingACCS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ACCS Yearly Total Debt VS Total AssetsACCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 1.80, we must say that ACCS is in the distress zone and has some risk of bankruptcy.
ACCS has a Altman-Z score of 1.80. This is comparable to the rest of the industry: ACCS outperforms 48.41% of its industry peers.
ACCS has a debt to FCF ratio of 1.26. This is a very positive value and a sign of high solvency as it would only need 1.26 years to pay back of all of its debts.
ACCS has a better Debt to FCF ratio (1.26) than 73.14% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that ACCS is not too dependend on debt financing.
ACCS has a Debt to Equity ratio of 0.10. This is comparable to the rest of the industry: ACCS outperforms 53.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.26
Altman-Z 1.8
ROIC/WACCN/A
WACC11.29%
ACCS Yearly LT Debt VS Equity VS FCFACCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

ACCS has a Current Ratio of 0.75. This is a bad value and indicates that ACCS is not financially healthy enough and could expect problems in meeting its short term obligations.
ACCS has a Current ratio of 0.75. This is amonst the worse of the industry: ACCS underperforms 84.10% of its industry peers.
ACCS has a Quick Ratio of 0.75. This is a bad value and indicates that ACCS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.75, ACCS is doing worse than 84.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
ACCS Yearly Current Assets VS Current LiabilitesACCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ACCS have decreased strongly by -36.89% in the last year.
ACCS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.60% yearly.
ACCS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -32.00%.
Measured over the past years, ACCS shows a small growth in Revenue. The Revenue has been growing by 7.19% on average per year.
EPS 1Y (TTM)-36.89%
EPS 3Y-10.86%
EPS 5Y9.6%
EPS Q2Q%-37.5%
Revenue 1Y (TTM)-32%
Revenue growth 3Y1.76%
Revenue growth 5Y7.19%
Sales Q2Q%-21.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y5%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-16.01%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACCS Yearly Revenue VS EstimatesACCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ACCS Yearly EPS VS EstimatesACCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.56 indicates a correct valuation of ACCS.
ACCS's Price/Earnings ratio is rather cheap when compared to the industry. ACCS is cheaper than 85.16% of the companies in the same industry.
When comparing the Price/Earnings ratio of ACCS to the average of the S&P500 Index (26.25), we can say ACCS is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 14.17, the valuation of ACCS can be described as correct.
ACCS's Price/Forward Earnings ratio is rather cheap when compared to the industry. ACCS is cheaper than 84.45% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.15. ACCS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.56
Fwd PE 14.17
ACCS Price Earnings VS Forward Price EarningsACCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

ACCS's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACCS indicates a rather cheap valuation: ACCS is cheaper than 88.34% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.39
EV/EBITDA 350.65
ACCS Per share dataACCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACCS does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.11
PEG (5Y)1.62
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACCS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACCESS NEWSWIRE INC

NYSEARCA:ACCS (5/30/2025, 8:04:03 PM)

10.1151

+0.02 (+0.15%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners41.78%
Inst Owner ChangeN/A
Ins Owners22.44%
Ins Owner Change100%
Market Cap38.94M
Analysts82.86
Price Target13.26 (31.09%)
Short Float %0.06%
Short Ratio0.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-36.39%
Min EPS beat(2)-62.29%
Max EPS beat(2)-10.49%
EPS beat(4)1
Avg EPS beat(4)-21.68%
Min EPS beat(4)-62.29%
Max EPS beat(4)2.71%
EPS beat(8)2
Avg EPS beat(8)-25.47%
EPS beat(12)4
Avg EPS beat(12)-18.9%
EPS beat(16)6
Avg EPS beat(16)-9.39%
Revenue beat(2)0
Avg Revenue beat(2)-15.89%
Min Revenue beat(2)-22.56%
Max Revenue beat(2)-9.23%
Revenue beat(4)0
Avg Revenue beat(4)-9.35%
Min Revenue beat(4)-22.56%
Max Revenue beat(4)-1.08%
Revenue beat(8)0
Avg Revenue beat(8)-11.65%
Revenue beat(12)1
Avg Revenue beat(12)-9.09%
Revenue beat(16)3
Avg Revenue beat(16)-6.54%
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)-15.91%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-5.66%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.56
Fwd PE 14.17
P/S 1.81
P/FCF 15.39
P/OCF 13.33
P/B 1.26
P/tB N/A
EV/EBITDA 350.65
EPS(TTM)0.65
EY6.43%
EPS(NY)0.71
Fwd EY7.06%
FCF(TTM)0.66
FCFY6.5%
OCF(TTM)0.76
OCFY7.5%
SpS5.6
BVpS8.02
TBVpS-0.1
PEG (NY)3.11
PEG (5Y)1.62
Profitability
Industry RankSector Rank
ROA -11.14%
ROE -17.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.19%
FCFM 11.73%
ROA(3y)-5.74%
ROA(5y)-0.56%
ROE(3y)-11.6%
ROE(5y)-3.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.85%
GM growth 5Y1.91%
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.26
Debt/EBITDA 30.15
Cap/Depr 13.45%
Cap/Sales 1.81%
Interest Coverage N/A
Cash Conversion 2755.66%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 1.8
F-Score4
WACC11.29%
ROIC/WACCN/A
Cap/Depr(3y)14.81%
Cap/Depr(5y)14.14%
Cap/Sales(3y)1.67%
Cap/Sales(5y)1.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.89%
EPS 3Y-10.86%
EPS 5Y9.6%
EPS Q2Q%-37.5%
EPS Next Y5%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32%
Revenue growth 3Y1.76%
Revenue growth 5Y7.19%
Sales Q2Q%-21.34%
Revenue Next Year-16.01%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-227.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year244.06%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-31.46%
FCF growth 3Y-17.03%
FCF growth 5Y0.97%
OCF growth 1Y-21.96%
OCF growth 3Y-12.59%
OCF growth 5Y1.99%